Stratification of patients with breast cancer according to the ER-status revealed that patients with high levels of SOX4 have a significantly worse prognosis in the ER-positive tumor group, and a trend towards poor-prognosis in the ER-negative tumor group (Figure 7—figure supplement 1A). The gene discussed is SOX4; the disease is breast cancer.